Orbital Radiation for Graves Ophthalmopathy. A Report by the American Academy of Ophthalmology

Ophthalmology

Volumn 115, Issue 2, 2008, Pages 398-409

  Bradley, Elizabeth A ^a   Gower, Emily W ^a   Bradley, David J ^a   Meyer, Dale R ^a   Cahill, Kenneth V ^a   Custer, Philip L ^a   Holck, David E ^a   Woog, John J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CUSHINGOID SYNDROME; DATA BASE; ENDOCRINE OPHTHALMOPATHY; EVIDENCE BASED MEDICINE; EXOPHTHALMOS; EYELID SWELLING; FOLLOW UP; HAIR LOSS; HEADACHE; HUMAN; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDICAL SOCIETY; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; OPTIC NERVE DISEASE; PALPEBRAL FISSURE; PATIENT SAFETY; PATIENT SELECTION; PERIORBITAL EDEMA; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; REVIEW; RISK ASSESSMENT; SWELLING; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ACADEMIES AND INSTITUTES; GRAVES OPHTHALMOPATHY; HUMANS; OPHTHALMOLOGY; ORBIT; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RADIATION INJURIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 38549107069     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.10.028     Document Type: Review

References (22)

1. Thomas Jr. H.M., and Woods A.C. Progressive exophthalmus following thyroidectomy. Bull Johns Hopkins Hosp 59 (1936) 99-113
2. Stern J.M., and Simes R.J. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 315 (1997) 640-645
3. Centre for Evidence-Based Medicine. Levels of evidence. http://www.cebm.net/levels_of_evidence.asp Accessed September 28, 2007
4. Juni P., Altman D.G., and Matthias E. Assessing the quality of randomised controlled trials. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. (2001), BMJ Publishing Group, London 87-108
5. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
6. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
7. Yaphe J., Edman R., Knishkowy B., and Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract 18 (2001) 565-568
8. Bartalena L., Marcocci C., Tanda M.L., et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129 (1998) 632-635
9. Marcocci C., Bartalena L., Rocchi R., et al. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 88 (2003) 3561-3566
10. Wakelkamp I.M., Tan H., Saeed P., et al. Orbital irradiation for Graves' ophthalmopathy: is it safe?. A long-term follow-up study. Ophthalmology 111 (2004) 1557-1562
11. Marquez S.D., Lum B.L., McDougall I.R., et al. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 51 (2001) 766-774
12. Schaefer U., Hesselmann S., Micke O., et al. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 52 (2002) 192-197
13. Bartalena L., Marcocci C., Chiovato L., et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56 (1983) 1139-1144
14. Antonelli A., Saracino A., Alberti B., et al. High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol (Copenh) 126 (1992) 13-23
15. Gerling J., Kommerell G., Henne K., et al. Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy. Int J Radiat Oncol Biol Phys 55 (2003) 182-189
16. Kahaly G.J., Rosler H.P., Pitz S., and Hommel G. Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 85 (2000) 102-108
17. Mourits M.P., van Kempen-Harteveld M.L., Garcia M.B., et al. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 355 (2000) 1505-1509
18. Ng C.M., Yuen H.K., Choi K.L., et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. Hong Kong Med J 11 (2005) 322-330
19. Prummel M.F., Mourits M.P., Blank L., et al. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 342 (1993) 949-954
20. Prummel M.F., Terwee C.B., Gerding M.N., et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab 89 (2004) 15-20
21. Gorman C.A., Garrity J.A., Fatourechi V., et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 108 (2001) 1523-1534
22. Robertson D.M., Buettner H., Gorman C.A., et al. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol 121 (2003) 652-657